NOAEL Studies
Cosmetic Ingredient
HC Orange No. 2 NOAEL Studies
INCI: HC ORANGE NO. 2
CAS: 85765-48-6
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
COSMOS DB 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| COSMOS DB | LOAEL | 5 | mg/kg bw/day | rat | oral | 6-19 Gestation day | Developmental | SCCP; G. Chevalier. HC Orange N°2 (B067): Prenatal Developmental Toxicity Study by OralRoute (Gavage) in Rats. CIT Study No. 26898 RSR, 2005 |
SCCS Opinion 9 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCS Opinion | NOAEL | =150 | mg/kg/day | rat | oral | 90 day | dermal absorption | p.5 |
| SCCS Opinion | NOAEL | =500 | mg/kg/day | - | - | Chronic | genotoxicity | p.16 |
| SCCS Opinion | NOAEL | =100 | mg/kg/day | rat | oral | developmental | developmental toxicity | p.21 |
| SCCS Opinion | NOAEL | =20 | mg/kg/day | - | - | - | NOAEL study | p.21 |
| SCCS Opinion | NOAEL | =0.016 | mg/kg | rat | oral | - | dermal absorption | p.22 |
| SCCS Opinion | NOAEL | =20 | mg/kg bw | rat | oral | - | dermal absorption | p.22 |
| SCCS Opinion | NOAEL | =150 | mg/kg bw | - | - | 90-day | NOAEL study | p.22 |
| SCCS Opinion | NOAEL | =100 | mg/kg bw/day | - | - | 90-day | NOAEL study | p.22 |
| SCCS Opinion | NOAEL | =500 | mg/kg bw/day | rabbit | - | developmental | developmental toxicity | p.23 |
Regulatory source 12 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| Regulatory source | - | 20 | mg/kg/day | - | - | - | - | p.21 |
| Regulatory source | - | 500 | mg/kg/day | - | - | - | - | p.21 |
| Regulatory source | - | 150 | mg/kg bw | - | - | 90-day | - | p.22 |
| Regulatory source | - | 100 | mg/kg bw/day | - | - | 90-day | - | p.22 |
| Regulatory source | dermal absorption | 150 | mg/kg/day | rat | oral | 90 day | dermal absorption | p.5 |
| Regulatory source | dermal absorption | =0.016 | mg/kg | rat | oral | - | dermal absorption | p.22 |
| Regulatory source | dermal absorption | =20 | mg/kg bw | rat | oral | - | dermal absorption | p.22 |
| Regulatory source | developmental toxicity | 100 | mg/kg/day | rat | oral | developmental | developmental toxicity | p.21 |
| Regulatory source | developmental toxicity | 20 | mg/kg/day | rabbit | - | developmental | developmental toxicity | p.23 |
| Regulatory source | developmental toxicity | 500 | mg/kg bw/day | rabbit | - | developmental | developmental toxicity | p.23 |
| Regulatory source | developmental toxicity | 100 | mg/kg bw/day | rabbit | - | developmental | developmental toxicity | p.23 |
| Regulatory source | genotoxicity | 500 | mg/kg/day | - | - | Chronic | genotoxicity | p.16 |
openFDA substances 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | 86WS98470U | UNII | - | - | - | chemical | - |